Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · CFR · Title 21 — Food and Drugs · Part 882 — Neurological Devices · § 882.5803

§ 882.5803. Digital therapy device for Attention Deficit Hyperactivity Disorder.

254 words·~1 min read·/us/cfr/t21/s§ 882.5803·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

(a)Identification. A digital therapy device for Attention Deficit Hyperactivity Disorder
(ADHD)is a software intended to provide therapy for ADHD or any of its individual symptoms as an adjunct to clinician supervised treatment.
(b)Classification. Class II (special controls). The special controls for this device are:
(1)Clinical performance testing must demonstrate and document the following under the labeled conditions for use, which include considerations for the ability of the device to:
(i)Use a validated measure to evaluate effectiveness of device to provide therapy for ADHD or any of its individual symptoms; and
(ii)Capture all adverse events.
(2)Software must be described and provided in a clear and detailed manner to include all features and functions of the software implementing the digital therapy. Software verification, validation, and hazard analysis must also be provided.
(3)The labeling must include the following items:
(i)Patient and physician labeling must include instructions for use, including images that demonstrate how to interact with the device;
(ii)Patient and physician labeling must list the minimum operating system
(OS)requirements that support the software of the device;
(iii)Patient and physician labeling must include a warning that the digital therapy device is not intended for use as a standalone therapeutic device;
(iv)Patient and physician labeling must include a warning that the digital therapy device does not represent a substitution for the patient's medication; and
(v)Physician labeling must include a summary of the clinical performance testing conducted with the device. [89 FR 71156, Sept. 3, 2024]
Connections19 cite this
Citation graph
cites case law
§ 882.5803
Digital therapy device for Attention Deficit Hyperactivity Disorder.
Fed. Reg.×19
Cites 0Cited by 19 across 1 source
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.